Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Ubisoft shares slump 20% after French video game maker warns on revenue

by Staff GBAF Publications Ltd
0 comment

By Dominique Vidalon

PARIS (Reuters) -Shares in Ubisoft fell 20% on Thursday after the French video game maker warned on revenue and postponed the release of its game “Skull and Bones”, prompting analysts to cut their estimates and price targets.

Late on Wednesday, Ubisoft said that it was increasing its writedown estimate to 500 million euros ($538 million) from 400 million and cutting its full-year revenue target after ending 2022 with weaker-than-expected sales.

Ubisoft cited the deteriorating economy, marked by lower spending on non-essential goods.

JP Morgan analysts in a note cut their rating on Ubisoft to “neutral” from “overweight”, citing “a weakening macro, a challenging industry environment and the lack of visibility regarding the timing of releases and their potential success”.

Several analysts noted that another negative factor was a shift in the video game industry towards mega-brands and away from small and mid-tier games.

“We have felt for several years that Ubisoft was devoting far too much money towards non A-tier franchises (such as Skull & Bones)”….Macro or not, there is still plenty of room for big performance if you have the right product…Ubisoft clearly needs to refocus its efforts,” Cowen analysts wrote.

They reiterated their “market perform” rating on Ubisoft and cut their price target to 22 euros from 34 euros.

Morningstar analysts cut their fair value estimate on Ubisoft to 35 euros from 60 euros “to account for the revenue drop, lower top-line growth, and potential further game delay”

Ubisoft shares were down 19.48% at 19.38 euros as of 0808 GMT.

(Reporting by Dominique Vidalon, Pitr Lipinski; editing by Benoit Van Overstraeten and Jason Neely)